As Washington grapples with rising drug costs, the state of Vermont is edging closer to adopting a program that would designate wholesalers to buy medicines from across the border in Canada.

The Vermont Agency for Human Services late last week completed a report showing the scheme could save up to $5 million annually on just 17 medicines for which two of the state’s three commercial health insurers spent the most money earlier this year. The forecast included a potential 45 percent mark-up on medicines.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Complete lunacy.

    Report says that savings are $1 to $5 million per year. That’s a less impressive figure than the “up to $5 million” stated in article.

    Most importantly: “These savings for commercial payers, post mark-up, do not take into consideration the State’s costs in operating a program of
    wholesale prescription drug importation. ”

    So, Vermont is going to build its own FDA? LOL! Good luck with that. Caveat emptor!

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy